AbstractMounting evidence suggests that microRNA (miR) dysregulation contributes to neurodegenerative disorders including Parkinson’s disease (PD). MiR-34b and miR-34c have been previously shown to be down-regulated in the brains of patients with PD. Here, we demonstrate that miR-34b and miR-34c repress the expression of α-synuclein (α-syn), a key protein in PD pathogenesis. Inhibition of miR-34b and miR-34c expression in human dopaminergic SH-SY5Y cells increased α-syn levels and stimulated aggregate formation. Additionally, a single nucleotide polymorphism (SNP) in the 3′-UTR of α-syn was found to lower the miR-34b-mediated repression of the protein. Our results suggest that down-regulation of miR-34b and miR-34c in the brain, as well as ...
Parkinson’s disease (PD) is a prevalent neurodegenerative disorder with pathological features includ...
miRNAs were recently implicated in the pathogenesis of numerous diseases, including neurological dis...
Abnormal alpha-synuclein (α-synuclein) expression and aggregation is a key characteristic of Parkins...
AbstractMounting evidence suggests that microRNA (miR) dysregulation contributes to neurodegenerativ...
Parkinson’s Disease (PD) is a neurodegenerative disorder that causes impaired motor control, tremors...
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Its neuropathological...
A group of circulating microRNAs (miRNAs) have been implicated in the pathogenesis of Parkinson’s di...
A group of circulating microRNAs (miRNAs) have been implicated in the pathogenesis of Parkinson’s di...
A group of circulating microRNAs (miRNAs) have been implicated in the pathogenesis of Parkinson’s di...
A group of circulating microRNAs (miRNAs) have been implicated in the pathogenesis of Parkinson’s di...
A group of circulating microRNAs (miRNAs) have been implicated in the pathogenesis of Parkinson’s di...
A group of circulating microRNAs (miRNAs) have been implicated in the pathogenesis of Parkinson’s di...
<div><p>Parkinson’s disease (PD) is a prevalent neurodegenerative disorder with pathological feature...
Parkinson\u27s disease (PD) is a neurodegenerative disorder with no cure. The pathological hallmark ...
Parkinson’s disease (PD) is a neurodegenerative synucleinopathy that has a not yet fully understood ...
Parkinson’s disease (PD) is a prevalent neurodegenerative disorder with pathological features includ...
miRNAs were recently implicated in the pathogenesis of numerous diseases, including neurological dis...
Abnormal alpha-synuclein (α-synuclein) expression and aggregation is a key characteristic of Parkins...
AbstractMounting evidence suggests that microRNA (miR) dysregulation contributes to neurodegenerativ...
Parkinson’s Disease (PD) is a neurodegenerative disorder that causes impaired motor control, tremors...
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Its neuropathological...
A group of circulating microRNAs (miRNAs) have been implicated in the pathogenesis of Parkinson’s di...
A group of circulating microRNAs (miRNAs) have been implicated in the pathogenesis of Parkinson’s di...
A group of circulating microRNAs (miRNAs) have been implicated in the pathogenesis of Parkinson’s di...
A group of circulating microRNAs (miRNAs) have been implicated in the pathogenesis of Parkinson’s di...
A group of circulating microRNAs (miRNAs) have been implicated in the pathogenesis of Parkinson’s di...
A group of circulating microRNAs (miRNAs) have been implicated in the pathogenesis of Parkinson’s di...
<div><p>Parkinson’s disease (PD) is a prevalent neurodegenerative disorder with pathological feature...
Parkinson\u27s disease (PD) is a neurodegenerative disorder with no cure. The pathological hallmark ...
Parkinson’s disease (PD) is a neurodegenerative synucleinopathy that has a not yet fully understood ...
Parkinson’s disease (PD) is a prevalent neurodegenerative disorder with pathological features includ...
miRNAs were recently implicated in the pathogenesis of numerous diseases, including neurological dis...
Abnormal alpha-synuclein (α-synuclein) expression and aggregation is a key characteristic of Parkins...